We are live on ! Find out more
CALA

Calithera Biosciences, Inc

Delisted

CALA was delisted on the 1st of February, 2023.

74 hedge funds and large institutions have $226M invested in Calithera Biosciences, Inc in 2017 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,020% more capital invested

Capital invested by funds: $20.1M → $226M (+$206M)

900% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 5

124% more funds holding

Funds holding: 3374 (+41)

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

16% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $1.52M

Holders
74
Holders Change
+41
Holders Change %
+124.24%
% of All Funds
1.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
50
Increased
14
Reduced
7
Closed
5
Calls
$1.28M
Puts
$1.52M
Net Calls
-$241K
Net Calls Change
-$242K
Name Holding Trade Value Shares
Change
Change in
Stake
IBT
26
International Biotechnology Trust
United Kingdom
$1.08M +$806K +4,665 New
Millennium Management
27
Millennium Management
New York
$870K +$551K +3,190 +554%
FSA
28
Franklin Street Advisors
North Carolina
$861K -$432K -2,500 -40%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$833K -$47.3K -274 -7%
LCM
30
Laurion Capital Management
New York
$504K +$377K +2,180 New
Simplex Trading
31
Simplex Trading
Illinois
$498K +$339K +1,960 +990%
Barclays
32
Barclays
United Kingdom
$409K +$306K +1,770 New
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$381K +$285K +1,651 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$377K +$42K +243 +17%
USAA
35
United Services Automobile Association
Texas
$342K +$256K +1,480 New
GCP
36
GSA Capital Partners
United Kingdom
$327K +$245K +1,417 New
OAM
37
Oxford Asset Management
United Kingdom
$326K -$184K -1,064 -43%
SCM
38
Segantii Capital Management
Hong Kong
$324K +$242K +1,402 New
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$269K +$10.9K +63 +6%
Northern Trust
40
Northern Trust
Illinois
$268K +$49.6K +287 +33%
IC
41
Iconiq Capital
California
$268K +$201K +1,161 New
State Street
42
State Street
Massachusetts
$255K +$191K +1,105 New
EMG
43
Ellington Management Group
Connecticut
$241K +$181K +1,045 New
Charles Schwab
44
Charles Schwab
California
$237K +$177K +1,025 New
Jane Street
45
Jane Street
New York
$222K +$166K +961 New
TRSOTSOK
46
Teachers Retirement System of the State of Kentucky
Kentucky
$214K +$160K +925 New
SG Americas Securities
47
SG Americas Securities
New York
$211K +$158K +914 New
LPL Financial
48
LPL Financial
California
$195K +$151K +873 New
CAM
49
ClariVest Asset Management
California
$194K +$145K +838 New
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$163K

CALA Hedge Fund Activity: Q1 2017 in Review

74 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2017, worth a combined $226M — up 1,020% from $20.1M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new CALA positions and 5 closed out — a net gain of 45 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $35.6M. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $1.42M sold.

  • 74 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2017, up from 33 in Q4 2016.
  • Funds reported $226M of Calithera Biosciences, Inc stock for Q1 2017, up 1,020% quarter-over-quarter.
  • 50 funds opened new Calithera Biosciences, Inc positions in Q1 2017 and 5 closed out, a net change of +45 holders.
  • The largest Calithera Biosciences, Inc buyer in Q1 2017 was Wellington Management Group, an estimated $35.6M added.
  • The largest Calithera Biosciences, Inc seller in Q1 2017 was First Eagle Investment Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q1 2017.